BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12388724)

  • 21. Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.
    da Fonseca FG; Wolffe EJ; Weisberg A; Moss B
    J Virol; 2000 Aug; 74(16):7518-28. PubMed ID: 10906205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
    Blasco R; Moss B
    J Virol; 1991 Nov; 65(11):5910-20. PubMed ID: 1920620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein.
    Geada MM; Galindo I; Lorenzo MM; Perdiguero B; Blasco R
    J Gen Virol; 2001 Nov; 82(Pt 11):2747-2760. PubMed ID: 11602786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.
    McIntosh AA; Smith GL
    J Virol; 1996 Jan; 70(1):272-81. PubMed ID: 8523536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail.
    Lorenzo MM; Herrera E; Blasco R; Isaacs SN
    Virology; 1998 Dec; 252(2):450-7. PubMed ID: 9878625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.
    Ortiz MA; Paez E
    Virology; 1994 Jan; 198(1):155-68. PubMed ID: 8259650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene.
    Roper RL; Payne LG; Moss B
    J Virol; 1996 Jun; 70(6):3753-62. PubMed ID: 8648710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mutational analysis of the vaccinia virus B5R protein.
    Mathew EC; Sanderson CM; Hollinshead R; Smith GL
    J Gen Virol; 2001 May; 82(Pt 5):1199-1213. PubMed ID: 11297695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.
    Blasco R; Moss B
    J Virol; 1992 Jul; 66(7):4170-9. PubMed ID: 1602540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus.
    Wolffe EJ; Katz E; Weisberg A; Moss B
    J Virol; 1997 May; 71(5):3904-15. PubMed ID: 9094667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo.
    Vijaysri S; Talasela L; Mercer AA; Mcinnes CJ; Jacobs BL; Langland JO
    Virology; 2003 Sep; 314(1):305-14. PubMed ID: 14517083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccinia Virus A6 Is a Two-Domain Protein Requiring a Cognate N-Terminal Domain for Full Viral Membrane Assembly Activity.
    Meng X; Rose L; Han Y; Deng J; Xiang Y
    J Virol; 2017 May; 91(10):. PubMed ID: 28275183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccinia virus utilizes microtubules for movement to the cell surface.
    Hollinshead M; Rodger G; Van Eijl H; Law M; Hollinshead R; Vaux DJ; Smith GL
    J Cell Biol; 2001 Jul; 154(2):389-402. PubMed ID: 11470826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L protein.
    Roper RL; Moss B
    J Virol; 1999 Feb; 73(2):1108-17. PubMed ID: 9882312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A36-dependent actin filament nucleation promotes release of vaccinia virus.
    Horsington J; Lynn H; Turnbull L; Cheng D; Braet F; Diefenbach RJ; Whitchurch CB; Karupiah G; Newsome TP
    PLoS Pathog; 2013 Mar; 9(3):e1003239. PubMed ID: 23555252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similarities in the induction of post-Golgi vesicles by the vaccinia virus F13L protein and phospholipase D.
    Husain M; Moss B
    J Virol; 2002 Aug; 76(15):7777-89. PubMed ID: 12097590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insertional inactivation of a fowlpox virus homologue of the vaccinia virus F12L gene inhibits the release of enveloped virions.
    Ogawa R; Calvert JG; Yanagida N; Nazerian K
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():55-64. PubMed ID: 8380837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses.
    Betakova T; Wolffe EJ; Moss B
    J Virol; 2000 May; 74(9):4085-92. PubMed ID: 10756020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The envelope G3L protein is essential for entry of vaccinia virus into host cells.
    Izmailyan RA; Huang CY; Mohammad S; Isaacs SN; Chang W
    J Virol; 2006 Sep; 80(17):8402-10. PubMed ID: 16912291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.